These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 39339748)
1. An Oral Botanical Supplement Improves Small Intestinal Bacterial Overgrowth (SIBO) and Facial Redness: Results of an Open-Label Clinical Study. Min M; Nadora D; Chakkalakal M; Afzal N; Subramanyam C; Gahoonia N; Pan A; Thacker S; Nong Y; Chambers CJ; Sivamani RK Nutrients; 2024 Sep; 16(18):. PubMed ID: 39339748 [TBL] [Abstract][Full Text] [Related]
2. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome. Zhuang X; Tian Z; Luo M; Xiong L BMC Gastroenterol; 2020 Jun; 20(1):187. PubMed ID: 32532214 [TBL] [Abstract][Full Text] [Related]
3. [Clinical features of irritable bowel syndrome with small intestinal bacterial overgrowth and a preliminary study of effectiveness of Rifaximin]. Liu ZJ; Wei H; Duan LP; Zhu SW; Zhang L; Wang K Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1896-902. PubMed ID: 27373356 [TBL] [Abstract][Full Text] [Related]
4. Effect of Bifidobacterium infantis 35624 (Align) on the Lactulose Breath Test for Small Intestinal Bacterial Overgrowth. Kumar K; Saadi M; Ramsey FV; Schey R; Parkman HP Dig Dis Sci; 2018 Apr; 63(4):989-995. PubMed ID: 29397491 [TBL] [Abstract][Full Text] [Related]
5. Lubiprostone Accelerates Intestinal Transit and Alleviates Small Intestinal Bacterial Overgrowth in Patients With Chronic Constipation. Sarosiek I; Bashashati M; Alvarez A; Hall M; Shankar N; Gomez Y; McCallum RW; Sarosiek J Am J Med Sci; 2016 Sep; 352(3):231-8. PubMed ID: 27650225 [TBL] [Abstract][Full Text] [Related]
6. Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome. Boltin D; Perets TT; Shporn E; Aizic S; Levy S; Niv Y; Dickman R Ann Clin Microbiol Antimicrob; 2014 Oct; 13():49. PubMed ID: 25319626 [TBL] [Abstract][Full Text] [Related]
7. A study of the methodological and clinical validity of the combined lactulose hydrogen breath test with scintigraphic oro-cecal transit test for diagnosing small intestinal bacterial overgrowth in IBS patients. Zhao J; Zheng X; Chu H; Zhao J; Cong Y; Fried M; Fox M; Dai N Neurogastroenterol Motil; 2014 Jun; 26(6):794-802. PubMed ID: 24641100 [TBL] [Abstract][Full Text] [Related]
8. Small Intestinal Transit Time Is Delayed in Small Intestinal Bacterial Overgrowth. Roland BC; Ciarleglio MM; Clarke JO; Semler JR; Tomakin E; Mullin GE; Pasricha PJ J Clin Gastroenterol; 2015 Aug; 49(7):571-6. PubMed ID: 25319735 [TBL] [Abstract][Full Text] [Related]
9. Intestinal permeability and small intestine bacterial overgrowth in excess weight adolescents. Cortez APB; Fisberg M; de Morais MB Pediatr Obes; 2021 May; 16(5):e12741. PubMed ID: 33089672 [TBL] [Abstract][Full Text] [Related]
11. Does Carbohydrate Challenge Testing Predict Clinical Response in Small Intestinal Bacterial Overgrowth? Long SK; Di Palma JA South Med J; 2016 May; 109(5):296-9. PubMed ID: 27135726 [TBL] [Abstract][Full Text] [Related]
12. Methane production and small intestinal bacterial overgrowth in children living in a slum. Mello CS; Tahan S; Melli LC; Rodrigues MS; de Mello RM; Scaletsky IC; de Morais MB World J Gastroenterol; 2012 Nov; 18(41):5932-9. PubMed ID: 23139610 [TBL] [Abstract][Full Text] [Related]
13. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture. Ghoshal UC; Srivastava D; Ghoshal U; Misra A Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):753-60. PubMed ID: 24849768 [TBL] [Abstract][Full Text] [Related]
14. The relationship between small intestinal bacterial overgrowth and irritable bowel syndrome. Ding XW; Liu YX; Fang XC; Liu K; Wei YY; Shan MH Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5191-5196. PubMed ID: 29228433 [TBL] [Abstract][Full Text] [Related]
15. Breath testing for small intestinal bacterial overgrowth: maximizing test accuracy. Saad RJ; Chey WD Clin Gastroenterol Hepatol; 2014 Dec; 12(12):1964-72; quiz e119-20. PubMed ID: 24095975 [TBL] [Abstract][Full Text] [Related]
16. Double-Blind Placebo-Controlled Study of Rifaximin and Lactulose Hydrogen Breath Test in Gulf War Veterans with Irritable Bowel Syndrome. Tuteja AK; Talley NJ; Stoddard GJ; Verne GN Dig Dis Sci; 2019 Mar; 64(3):838-845. PubMed ID: 30370492 [TBL] [Abstract][Full Text] [Related]
17. A meta-analysis on small intestinal bacterial overgrowth in patients with different subtypes of irritable bowel syndrome. Ghoshal UC; Nehra A; Mathur A; Rai S J Gastroenterol Hepatol; 2020 Jun; 35(6):922-931. PubMed ID: 31750966 [TBL] [Abstract][Full Text] [Related]
18. Clinical value of radionuclide small intestine transit time measurement combined with lactulose hydrogen breath test for the diagnosis of bacterial overgrowth in irritable bowel syndrome. Ning Y; Lou C; Huang Z; Chen D; Huang H; Chen L; Zhang B; Dai N; Zhao J; Zhen X Hell J Nucl Med; 2016; 19(2):124-9. PubMed ID: 27331205 [TBL] [Abstract][Full Text] [Related]
19. Gut dysbiosis and small intestinal bacterial overgrowth as independent forms of gut microbiota disorders in cirrhosis. Maslennikov R; Ivashkin V; Efremova I; Poluektova E; Kudryavtseva A; Krasnov G World J Gastroenterol; 2022 Mar; 28(10):1067-1077. PubMed ID: 35431497 [TBL] [Abstract][Full Text] [Related]
20. Fecal Coprococcus, hidden behind abdominal symptoms in patients with small intestinal bacterial overgrowth. Guo H; Chen Y; Dong W; Lu S; Du Y; Duan L J Transl Med; 2024 May; 22(1):496. PubMed ID: 38796441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]